Phase 1/2 and extension study of velaglucerase alfa replacement therapy in adults with type 1 Gaucher disease: 48-month experience
(Q39726002)
scientific article published on March 18, 2010
scientific article published on March 18, 2010
Language:
Current Data About
Phase 1/2 and extension study of velaglucerase alfa replacement therapy in adults with type 1 Gaucher disease: 48-month experience
other details
| description | scientific article published on March 18, 2010 |
External Links
| (P356) |
10.1182/BLOOD-2010-02-268649
|
| (P698) |
20299511
|